Does research into contraceptive method discontinuation address women's own reasons? A critical review

Journal of Family Planning and Reproductive Health Care

Volumn 41, Issue 4, 2015, Pages 292-299

  Inoue, Kumiyo ^a,b   Barratt, Alexandra ^c   Richters, Juliet ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF TASMANIA   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT;

AMENORRHEA; BARRIER CONTRACEPTION; CONDOM; CONTRACEPTIVE BEHAVIOR; COPPER INTRAUTERINE DEVICE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FEMALE FERTILITY; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; MEDICAL DEVICE COMPLICATION; PAIN; PATIENT COMPLIANCE; PATIENT SATISFACTION; PERSONAL EXPERIENCE; PREGNANCY; REVIEW; SPOTTING; SYSTEMATIC REVIEW; UNPLANNED PREGNANCY; UTERUS BLEEDING; VAGINA BLEEDING; WITHDRAWAL BLEEDING; ATTITUDE TO HEALTH; DECISION MAKING; METHODOLOGY;

ATTITUDE TO HEALTH; CHOICE BEHAVIOR; CONTRACEPTION BEHAVIOR; FEMALE; HUMANS; PATIENT SATISFACTION; RESEARCH DESIGN;

EID: 84942587071     PISSN: 14711893     EISSN: None     Source Type: Journal    
DOI: 10.1136/jfprhc-2014-100976     Document Type: Review

References (41)

1. Rosenberg MJ, Waugh MS. Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons. Am J Obstet Gynecol 1998;179:577-582
2. Sanders SA, Graham CA, Bass JL, et al. A prospective study of the effects of oral contraceptives on sexuality and well-being and their relationship to discontinuation. Contraception 2001;64:51-58
3. Westhoff CL, Heartwell S, Edwards S, et al. Oral contraceptive discontinuation: do side effects matter? Am J Obstet Gynecol 2007;196:412.e1-412.e7
4. Moreau C, Cleland K, Trussell J. Contraceptive discontinuation attributed to method dissatisfaction in the United States. Contraception 2007;76:267-272
5. Saldana J. The Coding Manual for Qualitative Researcher. Thousand Oaks, CA: Sage Publications, 2008.
6. Merki-Feld GS, Hund M. Clinical experience with Nuva Ring® in daily practice in Switzerland: cycle control and acceptability among women of all reproductive ages. Eur J Contracept Reprod Health Care 2007;12:240-247
7. Stewart FH, Kaunitz AM, Laguardia KD, et al. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial. Obstet Gynecol 2005;105:1389-1396
8. Archer DF, Jensen JT, Johnson JV, et al. Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results. Contraception 2006;74:439-445
9. Anderson FD, Hait H. A multicenter, randomized study of an extended cycle oral contraceptive. Contraception 2003;68:89-96
10. Lete I, Pérez-Campos E, Correa M, et al. Continuation rate of combined hormonal contraception: a prospective multicenter study. J Women's Health 2012;21:490-495
11. Matsumoto Y, Yamabe S, Sugishima T, et al. Perception of oral contraceptives among women of reproductive age in Japan: a comparison with the USA and France. J Obstet Gynaecol Res 2011;37:887-892
12. Edelman AB, Koontz SL, Nichols MD, et al. Continuous oral contraceptives: are bleeding patterns dependent on the hormones given? Obstet Gynecol 2006;107:657-665
13. Bachmann G, Sulak PJ, Sampson-Landers C, et al. Efficacy and safety of a low-dose 24-day combined oral contraceptive containing 20 micrograms ethinylestradiol and 3 mg drospirenone. Contraception 2004;70:191-198
14. Brunner Huber LR, Hogue CJ, Stein AD, et al. Contraceptive use and discontinuation: findings from the contraceptive history, initiation, and choice study. Am J Obstet Gynecol 2006;194:1290-1295
15. Harvey C, Seib C, Lucke J. Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia. Contraception 2009;80:527-532
16. Lete I, Del Carme Cuesta M, Marín JM, et al. Acceptability of the levonorgestrel intrauterine system in the long-term treatment of heavy menstrual bleeding: how many women choose to use a second device? Eur J Obstet Gynecol Reprod Biol 2011;154:67-70
17. Caruso S, Agnello C, Intelisano G, et al. Prospective study on sexual behavior of women using 30 microg ethinylestradiol and mg drospirenone oral contraceptive. Contraception 2005;72:19-23.
18. Drey EA, Reeves MF, Ogawa DD, et al. Insertion of intrauterine contraceptives immediately following first- and second-trimester abortions. Contraception 2009;79:397-402
19. Winkler UH, Ferguson H, Mulders JAPA. Cycle control, quality of life and acne with two low-dose oral contraceptives containing 20 μg ethinylestradiol. Contraception 2004;69:469-476
20. Jain J, Jakimiuk AJ, Bode FR, et al. Contraceptive efficacy and safety of DMPA-SC. Contraception 2004;70:269-275
21. Heger-Mahn D, Warlimont C, Faustmann T, et al. Combined ethinylestradiol/gestodene contraceptive patch: two-center, open-label study of ovulation inhibition, acceptability and safety over two cycles in female volunteers. Eur J Contracept Reprod Health Care 2004;9:173-181
22. Deokar AM, Jackson W, Omar HA. Menstrual bleeding patterns in adolescents using etonogestrel (ENG) implant. Int J Adolesc Med Health 2011;23:75-77
23. Rickert VI, Tiezzi L, Lipshutz J, et al. Depo now: preventing unintended pregnancies among adolescents and young adults. J Adolesc Health 2007;40:22-28
24. Thurman AR, Hammond N, Brown HE, et al. Preventing repeat teen pregnancy: postpartum depot medroxyprogesterone acetate, oral contraceptive pills, or the patch? J Pediatr Adolesc Gynecol 2007;20:61-65
25. Thomas AG, Klihr-Beall S, Siqueira L, et al. Concentration of depot medroxyprogesterone acetate and pain scores in adolescents: a randomized clinical trial. Contraception 2005;72:126-129
26. Brucker C, Karck U, Merkle E. Cycle control, tolerability, efficacy and acceptability of the vaginal contraceptive ring, Nuva Ring: results of clinical experience in Germany. Eur J Contracept Reprod Health Care 2008;13:31-38
27. Borgström A, Odlind V, Ekselius L, et al. Adverse mood effects of combined oral contraceptives in relation to personality traits. Eur J Obstet Gynecol Reprod Biol 2008;141:127-130
28. Borgström A, Kask K, Gulinello M, et al. Patients with adverse mood effects from combined oral contraceptives have lower levels of prepulse inhibition than healthy controls. Psychoneuroendocrinology 2008;33:487-496
29. Teal SB, Sheeder J. IUD use in adolescent mothers: retention, failure and reasons for discontinuation. Contraception 2012;85:270-274
30. Ersek JL, Brunner Huber LR, Thompson ME, et al. Satisfaction and discontinuation of contraception by contraceptive method among university women. Matern Child Health J 2011;15:497-506
31. Rai K, Gupta S, Cotter S. Experience with Implanon® in a north-east London family planning clinic. Eur J Contracept Reprod Health Care 2004;9:39-46
32. Short M, Dallay D, Omokanye S, et al. Acceptability of the levonorgestrel releasing-intrauterine system and etonogestrel implant: one-year results of an observational study. Eur J Contracept Reprod Health Care 2012;17:79-88
33. Oddsson K, Leifels-Fischer B, Wiel-Masson D, et al. Superior cycle control with a contraceptive vaginal ring compared with an oral contraceptive containing 30 microg ethinylestradiol and 150 microg levonorgestrel: a randomized trial. Hum Reprod 2005;20:557-562
34. Oddsson K, Leifels-Fischer B, de Melo NR, et al. Efficacy and safety of a contraceptive vaginal ring (Nuva Ring) compared with a combined oral contraceptive: a 1-year randomized trial. Contraception 2005;71:176-182
35. Gezginc K, Balci O, Karatayli R, et al. Contraceptive efficacy and side effects of Implanon®. Eur J Contracept Reprod Health Care 2007;12:362-365
36. Warner P, Guttinger A, Glasier AF, et al. Randomized placebocontrolled trial of CDB-2914 in new users of a levonorgestrel-releasing intrauterine system shows only short-lived amelioration of unscheduled bleeding. Hum Reprod 2010;25:345-353
37. Fennell J. 'And isn't that the point?' Pleasure and contraceptive decisions. Contraception 2014;89:264-270
38. Hayfield N, Clarke V. 'I'd be just as happy with a cup of tea': women's accounts of sex and affection in long-term heterosexual relationships. Women Stud Int Forum 2012;35:67-74
39. Binson D, Catania JA. Respondents' understanding of the words used in sexual behavior questions. Public Opin Q 1998;62:190-208
40. Heise LL. Beyond acceptability: reorienting research on contraceptive choice. In: Ravindran TKS, Berer M, Cottingham J (eds), Beyond Acceptability: Users' Perspectives on Contraception. London, UK: Reproductive Health Matters for the World Health Organization, 1997:6-14.
41. Hoggart L, Newton VL, Dickson J. 'I think it depends on the body, with mine it didn't work': explaining young women's decisions to request subdermal contraceptive implant removal. Contraception 2013;88:636-640